No retraction, correction or concern found when last checked on Nov 1, 2026.
SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection
Nils C. Gassen, Daniela Niemeyer, Doreen Muth and 16 more
Nature Communications · 2019 · CC BY
doi:10.1038/s41467-019-13659-4
Abstract
Autophagy is an essential cellular process affecting virus infections and other diseases and Beclin1 (BECN1) is one of its key regulators. Here, we identified S-phase kinase-associated protein 2 (SKP2) as E3 ligase that executes lysine-48-linked poly-ubiquitination of BECN1, thus promoting its proteasomal degradation. SKP2 activity is regulated by phosphorylation in a hetero-complex involving FKBP51, PHLPP, AKT1, and BECN1. Genetic or pharmacological inhibition of SKP2 decreases BECN1 ubiquitination, decreases BECN1 degradation and enhances autophagic flux. Middle East respiratory syndrome coronavirus (MERS-CoV) multiplication results in reduced BECN1 levels and blocks the fusion of autophagosomes and lysosomes. Inhibitors of SKP2 not only enhance autophagy but also reduce the replication of MERS-CoV up to 28,000-fold. The SKP2-BECN1 link constitutes a promising target for host-directed antiviral drugs and possibly other autophagy-sensitive conditions.
Cited by papers we hold 9
- Molecular pathways of major depressive disorder converge on the synapse · 2022No notice
- Autophagy: A Key Regulator of Homeostasis and Disease: An Overview of Molecular Mechanisms and Modulators · 2022No notice
- SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals · 2021No notice
- Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19 · 2021Not checked
- Therapeutic approaches against coronaviruses acute respiratory syndrome · 2021Not checked
- The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes · 2021No notice
- Autophagy in major human diseases · 2021No notice
- BECLIN1: Protein Structure, Function and Regulation · 2021No notice
- Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 · 2020No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.